BioCentury
ARTICLE | Clinical News

HinsBet: Phase IIa started

July 4, 2011 7:00 AM UTC

Adocia began a double-blind, German Phase IIa trial to compare 3 repeated injections of HinsBet vs. NovoLog insulin aspart in 20 Type I diabetics. Novo Nordisk A/S (CSE:NVO; NYSE:NVO, Bagsvaerd, Denm...